Telemedicine Approach for SARS-CoV-2 Self-Sampling
Author Information
Author(s): Florian Voit, Johanna Erber, Silvia Egert-Schwender, Michael Hanselmann, Michael Laxy, Victoria Kehl, Dieter Hoffmann, Samuel D Jeske, Thomas Michler, Ulrike Protzer, Florian Kohlmayer, Roland M Schmid, Christoph D Spinner, Simon Weidlich
Primary Institution: Technical University of Munich, Munich, Germany
Hypothesis
Is a telemedicine approach for SARS-CoV-2 testing feasible and satisfactory for users?
Conclusion
A telemedicine-based approach to SARS-CoV-2 testing is feasible and could improve user satisfaction and treatment quality.
Supporting Evidence
- 95% of telemedicine group participants received self-sampling kits.
- 76% of telemedicine group participants returned at least one sample.
- High satisfaction levels reported in the telemedicine group with ease of use and interface.
Takeaway
This study shows that people can collect their own COVID-19 tests at home using a mobile app, and most were happy with how it worked.
Methodology
Participants were randomly assigned to either a telemedicine group or a conventional testing group, with assessments of user satisfaction and feasibility.
Potential Biases
Potential nonresponse bias due to low questionnaire completion rate.
Limitations
The study had a small sample size and was conducted among medical staff, which may not represent the general population.
Participant Demographics
Mean age of participants was 38 years, with a majority being women (69.4% in TG).
Statistical Information
Confidence Interval
95% CI 12.9-20.5 for self-sampling time
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website